期刊文献+

雌、孕激素受体在宫颈癌及癌前病变中的表达及相关性研究 被引量:5

correlation and expression of ER,PR in cervical cancer and precancerous lesion
下载PDF
导出
摘要 目的:探讨雌激素受体(ER)、孕激素受体(PR)在不同程度的宫颈鳞状上皮病变中的表达及临床病理意义。方法:采用SP免疫组织化学染色法观察ER、PR在正常宫颈、宫颈上皮内瘤变(CIN)及宫颈癌中的表达情况。结果:ER在正常宫颈组中表达率为100%,随着病变程度的增加,其表达率及表达强度逐渐降低,在宫颈癌组仅为9.76%,各组间的差异具有显著的统计学意义(P<0.01)。PR在正常宫颈组织中的表达率不如ER的表达率高,为39.29%,随着病变程度的增加,其表达率也呈降低的趋势,在宫颈癌组其表达率已降至0,各组间的差异具有显著的统计学意义(P<0.01)。结论:ER、PR的表达与宫颈癌及癌前病变发生发展的关系密切,呈一定的负相关性。ER及PR的表达下调或缺失可能是导致宫颈癌发生的重要机制之一。 Objective:To explore the expression of ER,PR in the cervical cancer and its clinicopathologic significance.Methods: SP immunihistochemistry was used to detect the expression of ER,PR in normal cervical tissues,cervical intraepithelial neoplasm(CIN) and cervical cancers.Results: The positive rate of ER was 100% in the normal cervical tissue,its positive rate and staining intensity decreased with the severity of disease,only 9.76% in cervical cancer.There was significant difference(P0.01) between different groups.The positive rate of PR was lower than ER's,only 39.29% in the normal cervical tissue,its positive rate decreased with the severity of disease,0 in cervical cancer.There was significant difference(P0.01) between different groups.Cconclusion: The positive rate of ER and PR correlate closely with the development of the invasion cervical cancer and precancerous lesions.And ER,PR are negatively correlated with cervical lesions.Expression of ER and PR in cervical cancer was lower or deficient,which may play an important role in the pathogenesis of cervical cancer.
出处 《现代肿瘤医学》 CAS 2012年第5期1007-1010,共4页 Journal of Modern Oncology
基金 北京市海淀区科技项目(编号:K2008058)
关键词 宫颈鳞状细胞癌 宫颈上皮内瘤变 免疫组化 ER PR cervix squamous cell carcinoma cervical intraepithelial neoplasm immunohistry ER PR
  • 相关文献

参考文献11

  • 1Green G,Gonzalez A,Smith JS,et al.Human papillomavirus in-fection and use of oral contraceptives[J].Br J Cancer,2003,88:1713-1720.
  • 2Moreno V,Bosch FX,Munoz N,et al.Effect of oral contraceptiveson risk of cervical cancer in women with human papillomavirus in-fection:the IARC multicentric case-control study[J].Lancet,2002,359:1085-1092.
  • 3Moodley M,Moodley J,Chetty R,et al.The role of steroid cont-racettive hormones in the pathogenesis of invasive cervical cancer:areview[J].Int J Gynecol Cancer,2003,13(2):103-110.
  • 4Munoz N,Franceschi S,Bosetti C,et al.Role of parity and hu-manpapillomavirus in cervical cancer:the IARC multicentric case-control study[J].Lancet,2002,359:1093-1101.
  • 5Sethi S,Muller M,Schneider A,et al.Serologic response to theE4,E6,and E7 proteins of human papillomavirus type 16 in preg-nant women[J].Am J Obstet Gynecol,1998,178:360-364.
  • 6石新兰,黄利鸣,黎家华,姜玲.ER和PR在子宫颈的分布及其与宫颈鳞癌的关系[J].临床肿瘤学杂志,2002,7(2):88-90. 被引量:5
  • 7沈铿,杨树标,颜婉嫦,黄令翠,马钟可玑.子宫颈癌和正常宫颈组织雌、孕激素受体的研究[J].中华妇产科杂志,1994,29(5):284-288. 被引量:13
  • 8林素暇,吴秋良,侯景辉,郝亚萍.子宫颈癌组织中雌、孕激素受体的免疫组化研究[J].癌症,1998,17(5):389-390. 被引量:2
  • 9Castellsague X,Munoz N.Cofactors in human papillomavirus carci-nogenesise-role of parity,oral contraceptives,and tobacco smok-ing[J].J Natl Cancer Inst Monogr,2003,31:20-28.
  • 10Patricio Gariglio,Jorge Gutierrez.The role of retinoid deficiencyand estrogens as cofactors in cervical cancer[J].Archives MedRes,2009,40:449-465.

二级参考文献19

  • 1沈铿,杨树标,颜婉嫦,黄令翠,马钟可玑.子宫颈癌和正常宫颈组织雌、孕激素受体的研究[J].中华妇产科杂志,1994,29(5):284-288. 被引量:13
  • 2Wu Airu,Pract J Cancer,1987年,2卷,1页
  • 3Gao Yongliang,Am J Obstet Gynecol,1983年,146卷,229页
  • 4Young R H,Cancer,1982年,50卷,1384页
  • 5王福丰,中华妇产科杂志,1995年,30卷,563页
  • 6沈铿,中华妇产科杂志,1994年,29卷,284页
  • 7Gao Yongliang,Am J Obstet Gynecol,1983年,146卷,229页
  • 8Nonogaki H,Fujii S,Konishi I,et al.Estrogen receptor localization in normal and neoplastic epithelium of the uterine cervix[J].Cancer.1990,66(12):2620-2627.
  • 9Chaudhuri B,Crist KA,Mucci S J,et al.Estrogen receptor in carcinoma in situ of the cervix[J].J.Surg.Oncol.1992,49(2):103-106.
  • 10Han SW,He B,Tang QP.Cytosol estrogen and progesterone receptors in female genital system malignant tumors[J]. Chung Hua Fu Chan Ko Tsa Chih,1994, 29(1):12-15.

共引文献20

同被引文献59

  • 1喻琳麟,岳利民.GPR30/GPER介导雌激素快速效应的研究进展[J].生理科学进展,2013,44(6):437-441. 被引量:4
  • 2姜淑清,邓小虹,冉齐钢.妇女病普查工作体会[J].中国妇幼保健,2006,21(19):2647-2648. 被引量:7
  • 3李文金,赵春英.芳香化酶与乳腺癌的相关研究[J].国际外科学杂志,2007,34(1):55-58. 被引量:3
  • 4古扎丽努尔.阿不力孜,程静新,米克热木,古兰丹,李华,米合日尼沙,米日古丽,米日古丽.艾乃土,路玲.新疆维吾尔族妇女宫颈癌的HPV谱研究[J].肿瘤,2007,27(5):379-382. 被引量:48
  • 5Luhn P,Walker J , Schiffman M,et al. The role of co-factorsin the progression from human papillomavirus infection to cer-vical cancerQ]. Gynecol Oncol,2013,128(2) :265-270.
  • 6Au WW, Abdou-Salama S,Al-Hendy A. Inhibition of growthof cervical cancer cells using a dominant negative estrogen receptor gene[j]. Genecol Oncol, 2007,104 :276-280.
  • 7Jean-Christophe N, Dario B,Isabelle F,et al. Androgen re-ceptor expression in cervical intraepithelial neoplasia and in-vasive squamous cell carcinoma of the cervix C iJGynecol Pathol, 2008, 27:437-441.
  • 8Dillner J,Krogh GV,Horenblas S. Epidemiology of humanpapillomavirus infections [J ]. Scand J Urol Nephrol,2000,34:194-200.
  • 9Nair HB,Luthra R,Kirma N,et al. Induction of aromataseexpression in cervical carcinomas: effects of endogenous es-trogen on cervical cancer cell proliferation [J]. Cancer Res,2005, 65:11164-11173.
  • 10梁东霞(综述),张彦娜(审校).宫颈癌与hpv关系的研究进展[J].实用癌症杂志,2010,25(2):202-205. 被引量:56

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部